filmov
tv
Case 3: KRAS-Mutated Metastatic Colon Cancer
Показать описание
Michael Morse, MD, discusses the diagnosis of a 50-year-old woman with KRAS-mutated metastatic colon cancer and highlights recent data on next-generation sequencing (NGS).
Targeted Oncology
targeted oncology
oncology
cancer
Рекомендации по теме
0:07:57
Case 3: KRAS-Mutated Metastatic Colon Cancer
0:05:33
Treatment Options for KRAS-Mutant Unresectable mCRC
0:04:54
Case 1: BRAF-Mutated Metastatic Colorectal Cancer
0:07:20
Treating Metastatic Colorectal Cancer: Case Study Review
0:00:57
Dr. Cercek on the Need for Treatment Options in KRAS Mutated mCRC
0:05:06
Treatment Strategies for Left-Sided KRAS-Mutated CRC
0:09:25
Debate: MSI High Colon Cancer - Immunotherapy
0:03:46
Targeting Colorectal Cancer: KRAS and NRAS Mutations
0:05:52
Expanded RAS Mutation Testing in Metastatic Colorectal Cancer
0:08:39
PRIME Trial: RAS Mutations Defined in Colorectal Cancer
0:10:27
Introduction: Expanded RAS Mutation Testing in Colorectal Cancer
0:03:10
Case 4: Metastatic Colon Cancer, MSI-High
0:04:16
FIRE-3 Study: Cetuximab Versus Bevacizumab in Metastatic Colorectal Cancer
0:11:54
Debate: Targeted therapy for RAS/BRAF WT left sided colon cancers - Bevacizumab or EGFR antibodies
0:03:50
Case Study of a 33-Year-Old With Metastatic Colorectal Cancer
0:01:12
Targeted therapies in metastatic colorectal cancer
0:05:57
Case Studies in Advanced Colorectal Cancer
0:00:41
KRAS Driven Cancers (KRAS episode 2)
0:03:21
Newly Diagnosed mCRC Treatment Goals
0:04:20
Frontline Treatment for KRAS Wild-Type mCRC
0:22:10
Novel Agents and Targets in Colorectal Cancer
0:02:43
When to Order Next-Generation Sequencing for a Patient With Metastatic Colon Cancer
0:17:17
Debate: Targeted therapy for RAS/BRAF WT left sided colon cancers - EGFR antibodies are mandatory
0:04:55
Case 2: Metastatic Colon Cancer, No Molecular Alterations